Assessment of c-reactive protein level in oral submucous fibrosis and oral squamous cell carcinoma patient

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Potentially malignant disorders are highly prevalent in India. In this study, we assessed C-reactive protein (CRP) levels in patients with oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC). Methodology: Sixty-four patients (OSMF and OSCC) were undertaken and were classified into 3 groups, OSMF patients (Group I, 34), OSCC (Group II, 30), and healthy controls (Group III, 26). Immunoturbidimetry method was used for the estimation of CRP levels. Results: Maximum cases in Group I was seen in the age group 40-60 years (males-10, females-3), Group II in the age group 40-60 years (males-11, females-5) and Group III (males-5, females-6). The mean CRP level in Group I was 6.12 ± 4.5 mg/l, in Group II was 28.4 ± 21.5 mg/l, and in Group III was 3.15 ± 2.19 mg/l. The difference was significant (P < 0.05). Conclusion: Authors found that OSMF and oral cancer patients had increased CRP levels as compared to healthy subjects.

Cite

CITATION STYLE

APA

Sharma, G., Kumar, R., Salam, S., Bhasin, P., Tewari, N., & Yadav, S. (2021). Assessment of c-reactive protein level in oral submucous fibrosis and oral squamous cell carcinoma patient. Journal of Pharmacy and Bioallied Sciences, 13(5), S748–S750. https://doi.org/10.4103/jpbs.JPBS_607_20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free